Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
This study has been completed.
Information provided by:
First received: June 30, 2006
Last updated: May 30, 2007
Last verified: May 2007
To evaluate the IOP-lowering efficacy of bimatoprost 0.03% in patients found to be low-responders to latanoprost therapy.
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
|Official Title:||Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Innovative Medical:
Contacts and Locations